The Movement Disorder Society of Japan (MDSJ) was established in 2002 and was initially held as a satellite symposium of the Japanese Society of Neurology (JSN) with about 100 participants, but since 2007, it has been held as an independent meeting and the number of participants has increased year by year, and now it has grown to nearly 1,000 participants. At present, it has become the most important forum for the exchange of information for people in Japan specializing in Parkinson's disease and movement disorders.
In addition to the annual meeting, the society has held educational workshops since 2011, providing a place where medical professionals, including non-members, can learn basic knowledge about Parkinson's disease and related disorders. In 2015, the Society also started video forums in each region to study the symptoms of movement disorders using video clips. In 2016, the PD Nurse Training Course was started. Furthermore since 2022, it has been renamed to the PD Nurse Medical Staff Training Course to expand the range of covered medical occupations, and those who pass the post-training examination are certified as "Parkinson's Disease Care Instructors".
As the world population ages, the prevalence of Parkinson's disease and related disorders continues to increase dramatically, and the term "PD pandemic" has been coined. Japan has the highest rate of aging population in the world, and is now entering the era of "PD pandemic" ahead of the rest of the world. Nowadays, Parkinson's disease and related disorders require a multidisciplinary team of medical professionals, not just a few specialists. While we are still far from a cure, several disease-modifying therapies are under development with the aim of practical application, and it seems that we are one step closer to a cure. Through the activities of this society, we aim to raise awareness of Parkinson's disease and movement disorders in society as a whole, provide a training venue for all medical professionals to acquire correct knowledge, and promote active discussions to overcome the disease through the exchange of research information on the latest pathophysiology and treatment. Thank you for your kind supports.
June 16, 2022
The president of MDSJ